Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease

2024

Howe MD, Britton KJ, Joyce HE, Menard W, Emrani S, Kunicki ZJ, Faust MA, Dawson BC, Riddle MC, Huey ED, Janelidze S, Hansson O, Salloway SP.

Alzheimers Res Ther. 2024 Jul 6;16(1):154. doi: 10.1186/s13195-024-01521-9.PMID: 38971815 Free PMC article.